Coastal Infusion Administers Ocrevus®
| J-Code | J2350 |
|---|---|
| Manufacturer | Genentech |
| First Approved | 03/28/2017 |
Coastal Infusion can administer your Ocrevus prescription at any of our south Florida locations.
Ocrevus (ocrelizumab) is used to treat relapsing or primary progressive forms of multiple sclerosis (MS). It is used in patients with active disease, who have relapses and/or signs of active inflammation on scans.
The active substance in Ocrevus, ocrelizumab, is a monoclonal antibody (a type of protein) that has been designed to recognize and attach to a specific target called CD20 on the surface of B cells (a type of white blood cell). By targeting B cells, ocrelizumab helps to reduce their activity and helps to prevent flare-ups.
What It Treats
Ocrevus is used to treat multiple sclerosis.
Prescribed By
Ocrevus is most often prescribed by Neurologists.
How it’s Administered
Ocrevus is administered by intravenous infusion. Ocrevus infusions take about four hours.
Frequency
Ocrevus is administered every six months after a starter dose that is split into two separate infusions, two weeks apart.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies